English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Nicholas Gueguen
| Jun 30, 2017
Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Ruth de Jauregui
| May 3, 2017
Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
Robert Hadley
| Apr 28, 2017
Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh
| Feb 6, 2017
Shire takes lead on rare conditions, CEO says
Keri Carbaugh
| Jan 18, 2017
Shire again offers scholarship for students with ADHD
Amanda Rupp
| Jun 11, 2016
Shire shareholders approve Baxalta merger
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Apr 17, 2016
Shire sends application to FDA for chewable Vyvanse tablets
Trending
+
Regulatory
Patient Daily News Service
| Jan 12, 2025
National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+
Regulatory
Patient Daily reports
| Jan 14, 2025
National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
+
Pharmaceuticals
Patient Daily
| Jan 9, 2025
Research identifies diverse cell types in cochlear nucleus
+
Pharmaceuticals
Patient Daily
| Jan 10, 2025
Study reveals dynamics behind CAR T cell's ability to fight cancer
